Relationship between Mucosal Immune Response to Phosphorylcholineand atherosclerosis
| Project/Area Number |
23792515
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Social dentistry
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
GOTO Masaki 徳島大学, 大学院・ソシオテクノサイエンス研究部, 助教 (30507455)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
|---|
| Keywords | 粘膜免疫 / ホスホリルコリン / 動脈硬化 / 口腔常在菌 |
|---|
| Research Abstract |
Antibody levels in sera and mucosal secretions following the nasal vaccination with PC-KLH were facilitated by coadministration of LPS. LPS can be used as a mucosal adjuvant as an alternative to CT. From an epidemiological survey, antibody levels of the huma n anti-PC IgM in plasma associated with the risk for the atherosclerosis but the periodontal condition must be considered in analysis of the atherosclerosis.
|
Report
(3 results)
Research Products
(12 results)
